OUSTZ vs UTHR · rev $111.1M vs P/E 20, rev $1.56B
Ouster, Inc. Warrants (OUSTZ) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Ouster, Inc. Warrants (OUSTZ) is a electronic components company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported OUSTZ revenue for 2024-12-31 was $111.1M. Net income was -$97.0M. Revenue was up 33.4% from 2023-12-31 to 2024-12-31. OUSTZ currently screens at market cap $0.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
OUSTZ currently screens at market cap $0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the OUSTZ and UTHR stock pages for the full models.
Not investment advice.